Business Practice

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Here, James speaks with Christophe Le Ret from Umicore.

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Here, James speaks with Tony van Bijleveld from Thermo Fischer Scientific (Patheon).

Sitting Down With... Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.

We examine the most commercially important biotherapeutics now, and in the future.

China is upping its game with plans to revolutionize its manufacturing industries, including pharma.

Tommy Fanning believes that Ireland’s pharma industry will continue to thrive, despite tax cuts in the US and Brexit.

Consumer trust in pharma nosedives because of the “blame game.”